{
    "ticker": "CLPT",
    "name": "ClearPoint Neuro, Inc.",
    "description": "ClearPoint Neuro, Inc. is a leading technology company focused on advancing the field of neurosurgery through innovative platform technologies that enhance the precision and safety of minimally invasive procedures. Established in 2009, ClearPoint has developed a suite of proprietary solutions that utilize advanced imaging and navigation technologies to improve patient outcomes in the treatment of neurological disorders. The company's flagship product, the ClearPoint Neuro Navigation System, integrates real-time imaging with pre-operative planning, allowing surgeons to navigate complex brain structures with increased accuracy. ClearPoint's commitment to improving surgical techniques extends to their partnerships with leading research institutions and hospitals, facilitating the adoption of their technologies in clinical settings. Additionally, the company is actively involved in the development of new therapies for conditions such as Parkinson's disease and epilepsy, leveraging its platform to enable targeted drug delivery directly into the brain. With a mission to enhance the capabilities of neurosurgeons and transform the surgical landscape, ClearPoint Neuro continues to innovate and expand its product offerings, positioning itself as a key player in the neurosurgical market.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Boulder, Colorado, USA",
    "founded": "2009",
    "website": "https://www.clearpointneuro.com",
    "ceo": "Joe Burnett",
    "social_media": {
        "twitter": "https://twitter.com/ClearPointNeuro",
        "linkedin": "https://www.linkedin.com/company/clearpoint-neuro/"
    },
    "investor_relations": "https://www.clearpointneuro.com/investors",
    "key_executives": [
        {
            "name": "Joe Burnett",
            "position": "CEO"
        },
        {
            "name": "William McGarry",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Neurosurgical Navigation",
            "products": [
                "ClearPoint Neuro Navigation System",
                "SmartFlow Catheter"
            ]
        },
        {
            "category": "Drug Delivery Systems",
            "products": [
                "Cerebral Infusion Catheter"
            ]
        }
    ],
    "seo": {
        "meta_title": "ClearPoint Neuro, Inc. | Innovating Neurosurgical Solutions",
        "meta_description": "Explore ClearPoint Neuro, Inc., a leader in neurosurgical technology committed to improving surgical precision and patient outcomes through innovative solutions.",
        "keywords": [
            "ClearPoint Neuro",
            "Neurosurgery",
            "Medical Devices",
            "Brain Surgery",
            "Minimally Invasive Procedures"
        ]
    },
    "faq": [
        {
            "question": "What does ClearPoint Neuro specialize in?",
            "answer": "ClearPoint Neuro specializes in neurosurgical navigation and drug delivery systems for brain surgeries."
        },
        {
            "question": "Who is the CEO of ClearPoint Neuro?",
            "answer": "Joe Burnett is the CEO of ClearPoint Neuro, Inc."
        },
        {
            "question": "Where is ClearPoint Neuro headquartered?",
            "answer": "ClearPoint Neuro is headquartered in Boulder, Colorado, USA."
        },
        {
            "question": "What are some products offered by ClearPoint Neuro?",
            "answer": "ClearPoint Neuro offers products such as the ClearPoint Neuro Navigation System and the SmartFlow Catheter."
        },
        {
            "question": "When was ClearPoint Neuro founded?",
            "answer": "ClearPoint Neuro was founded in 2009."
        }
    ],
    "competitors": [
        "ISRG",
        "SYK",
        "ZBH"
    ],
    "related_stocks": [
        "MDT",
        "ABT",
        "BSX",
        "HOLX"
    ]
}